-

Conavi Medical and Japan Lifeline Announce MHLW Approval of Novasight Hybrid Intravascular Imaging System for Japanese Market

TORONTO--(BUSINESS WIRE)--ConaviTM Medical Inc. and Japan Lifeline are pleased to announce that they have received regulatory approval from the Ministry of Health, Labor and Welfare (MHLW) in Japan for the Novasight HybridTM intravascular imaging system. The Novasight Hybrid system is the world’s first clinical system capable of providing both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) on a single imaging catheter. The system also has Health Canada approval and FDA 510(k) clearance in the USA. Japan Lifeline is the exclusive distributor for this technology in Japan.

Dr. Brian Courtney, Conavi Medical’s Chief Executive Officer, comments that "We are delighted to have received MHLW approval of the Novasight Hybrid system. Clinical data in the past several years has increasingly demonstrated that intravascular imaging with either IVUS or OCT has significant potential to improve outcomes in the large number of patients being treated with angioplasty and stenting for coronary artery disease. However, there are substantial differences between the images generated by these two technologies. Until now, physicians in Japan have had to choose between IVUS or OCT when performing percutaneous coronary interventions (PCI). We are delighted that Conavi and Japan Lifeline can now begin to offer both of these highly complementary imaging techniques on a single catheter to physicians in Japan.”

About Conavi Medical:

Conavi Medical Inc. is a privately held Canadian company focused on designing, manufacturing, and selling imaging technologies to guide minimally invasive cardiovascular procedures. For more information, visit http://www.conavi.com/.

About Japan Lifeline Co., Ltd.

Japan Lifeline (JLL) is a manufacturer, importer and distributor of quality medical products. Japan Lifeline is a publicly traded company, ticker symbol TYO:7575. Visit the JLL website at: http://www.japanlifeline.com.

Contacts

Stefano Picone, Vice President, Finance & Business Development, Conavi Medical Inc.
p 416.483.0100
e media-relations@conavi.com

Industry:

Conavi Medical Inc.

Release Versions
English

Contacts

Stefano Picone, Vice President, Finance & Business Development, Conavi Medical Inc.
p 416.483.0100
e media-relations@conavi.com

More News From Conavi Medical Inc.

Conavi Medical’s Novasight Hybrid System Now In Use at Sunnybrook Health Sciences Centre

TORONTO--(BUSINESS WIRE)--Conavi Medical Inc. (www.conavi.com), a leader of hybrid imaging guidance for common minimally invasive heart procedures, and Sunnybrook Health Sciences Centre, today announced that the Novasight Hybrid System is now being used for clinical procedures by interventional cardiologists as part of the Schulich Heart Program. Sunnybrook’s Schulich Heart Program is one of Canada’s leading cardiac and vascular care centres with an international reputation for pioneering some...

Conavi Medical Plans for Strategic Expansion in U.S. Market

TORONTO--(BUSINESS WIRE)--Conavi Medical Inc. (www.conavi.com), a leader of hybrid imaging guidance for common minimally invasive heart procedures, plans to expand the presence of its Novasight Hybrid System in the U.S. market in 2022 under the guidance of its new leadership team. Thomas Looby, chief executive officer, Conavi Medical, appointed in April of 2021 to focus on the company’s strategic growth plans, has set the U.S. market as the company’s near-term focus. Looby’s extensive backgroun...

Conavi Medical Enters into Funding Agreements for Over $20 Million to Support Commercialization of its Innovative Intravascular Image Guidance Technology

TORONTO--(BUSINESS WIRE)--Conavi Medical Inc. enters into funding agreements for over $20 million to support commercialization and prepare Novasight Hybrid® System for market....
Back to Newsroom